PharmaCyte Biotech Inc (PMCB) Stock Price, Quote, News & History

PMCBNASDAQ
$0.7000
N/A
At close: Jun 9, 5:00 PM EST
$0.7140
0.0142.00%
Pre-Market: 8:03 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-4.80M
Investing Cash Flow (TTM)
2.00M
Financing Cash Flow (TTM)
6.58M
Free Cash Flow (TTM)
-4.80M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
3.78M

Valuation Metrics

Enterprise Value
-$12.15M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.20
Earnings Yield % (TTM)
-127.14%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.59

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$20.17M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$0.70
Volume / Avg.
0 / 191.60K
Day Range
- - -
52 Wk Range
0.63 - 1.51
Market Cap
$7.67M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
3.71%
Days to Cover
1.54

About

Sector
Health Care
Industry
Biotechnology
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy PharmaCyte Biotech (PMCB) stock?

A

You can purchase shares of PharmaCyte Biotech (NASDAQ:PMCB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are PharmaCyte Biotech (PMCB) competitors?

A

There are no as such competitors for PharmaCyte Biotech.

Q

What is the forecast, or price target, for PharmaCyte Biotech (PMCB) stock?

A

There is no analysis for PharmaCyte Biotech to provide a consensus price target.

Q

What is the current price for PharmaCyte Biotech (PMCB)?

A

The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $0.714 last updated June 10, 2026 at 4:44 PM EDT.

Q

Does PharmaCyte Biotech (PMCB) pay a dividend?

A

There are no upcoming dividends for PharmaCyte Biotech.

Q

When is PharmaCyte Biotech (NASDAQ:PMCB) reporting earnings?

A

PharmaCyte Biotech does not have any upcoming earnings scheduled.

Q

Is PharmaCyte Biotech (PMCB) going to split?

A

There is no upcoming split for PharmaCyte Biotech.

Q

What sector and industry does PharmaCyte Biotech (PMCB) operate in?

A

PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.